Corbus Pharmaceuticals Holdings, Inc. balance sheet

At the end of fiscal 2022, Corbus Pharmaceuticals Holdings, Inc. had total assets of $66.3m, total liabilities of $33.3m and shareholders' equity of $33.0m. It held $17.0m in cash against $21.9m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Corbus Pharmaceuticals Holdings, Inc.: balance sheet, annual
Fiscal year	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022
Cash and equivalents	12	15	63	42	32	85	25	17
Total current assets	13	17	66	44	38	92	100	60
Total assets	13	18	67	47	49	102	108	66
Accounts payable	1	3	3	6	11	7	2	2
Deferred revenue (current)	2	2	—	1	—	—	—	—
Total current liabilities	4	9	8	18	35	32	17	13
Short-term debt	—	—	—	—	—	—	3	3
Long-term debt	0	—	—	—	—	18	16	16
Total debt	0	—	0	0	1	22	22	22
Total liabilities	4	9	9	19	43	57	39	33
Shareholders' equity	9	9	58	28	6	45	69	33
Shares outstanding	—	—	—	—	—	—	4m	4m

US$ millions unless shown otherwise. Fiscal quarters.

Corbus Pharmaceuticals Holdings, Inc.: balance sheet, quarterly
Quarter	2020 Q4Dec 2020	2021 Q1Mar 2021	2021 Q2Jun 2021	2021 Q3Sept 2021	2021 Q4Dec 2021	2022 Q1Mar 2022	2022 Q3Sept 2022	2022 Q4Dec 2022
Total current assets	92	130	112	112	100	88	67	60
Total assets	102	140	121	120	108	96	74	66
Accounts payable	7	4	2	3	2	3	1	2
Total current liabilities	32	24	19	17	17	15	17	13
Short-term debt	—	—	—	—	3	5	10	3
Long-term debt	18	18	18	19	16	14	9	16
Total debt	18	18	18	19	19	19	19	19
Total liabilities	57	49	44	42	39	35	32	33
Shareholders' equity	45	92	77	78	69	61	42	33
Shares outstanding	99m	125m	125m	125m	4m	125m	125m	4m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Corbus Pharmaceuticals Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Corbus Pharmaceuticals Holdings, Inc.